Alnylam Pharmaceuticals
Price & Volume
Stats
See more52W Range | $284.28-$495.55 |
Market Cap | $39.4B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $4.2B |
Revenue Growth (YoY) | 96.4% |
Gross Profit (12 Mos) | $3.4B |
Diluted EPS | $3.99 |
News
See moreYahoo Finance • 9 days ago
JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms
Yahoo Finance • 10 days ago
StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls
Yahoo Finance • 10 days ago
Alnylam Issues 2025 Corporate Responsibility Report
About
CEO | Dr. Yvonne L. Greenstreet M.B.A., M.D. |
CFO | Mr. Jeffrey V. Poulton M.B.A. |
Address | 675 West Kendall Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,500 |